|
Aug 7
|
Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 7
|
Quanterix Releases Operating Results for Second Quarter 2023
|
|
Apr 25
|
FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials
|